These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8264912)

  • 1. Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease.
    Saint-Cyr JA; Taylor AE; Lang AE
    Neurology; 1993 Dec; 43(12 Suppl 6):S47-52. PubMed ID: 8264912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychiatric complications of L-dopa: physiopathology and treatment].
    Castro-García A
    Rev Neurol; 1997 Aug; 25 Suppl 2():S157-62. PubMed ID: 9280683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of disease and therapy: a comparison of younger and older patients with Parkinson's disease.
    Wagner ML; Fedak MN; Sage JI; Mark MH
    Ann Clin Lab Sci; 1996; 26(5):389-95. PubMed ID: 8879356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuropsychiatric disorders in Parkinson's disease].
    Noé-Sebastián E; Irimia-Sieira P; Pomares-Arias E; Martínez-Vila E; Luquin-Piudo MR
    Rev Neurol; 2001 Apr 1-15; 32(7):676-81. PubMed ID: 11391498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mental state of parkinsonian patients].
    Dubois B
    Rev Prat; 1989 Mar; 39(8):658-61. PubMed ID: 2727573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for early Parkinson's disease.
    Stacy M; Brownlee HJ
    Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
    Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emotional and cognitive disorders in Parkinson disease].
    Arsland D; Larsen JP
    Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug treatment is beneficial also for elderly patients with Parkinson disease. Important to consider also other co-existing diseases].
    Granérus AK
    Lakartidningen; 2001 Mar; 98(13):1515-23. PubMed ID: 11330147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
    Devos D;
    Mov Disord; 2009 May; 24(7):993-1000. PubMed ID: 19253412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy for Parkinson's disease.
    Hermanowicz N
    Semin Neurol; 2007 Apr; 27(2):97-105. PubMed ID: 17390254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parkinson syndrome: iatrogenic causes, iatrogenic treatment results].
    Burgunder JM
    Schweiz Med Wochenschr; 1996 Mar; 126(13):522-7. PubMed ID: 8658091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Motor complications of treatment with levodopa in Parkinson's disease].
    García-Escrig M; Bermejo-Pareja F
    Rev Neurol; 1999 Apr 16-30; 28(8):799-809. PubMed ID: 10363326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease: drug therapy.
    Oertel WH; Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):89-108. PubMed ID: 9426870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropsychic side effects of bromocriptine in Parkinson's disease].
    Simonetta M; Schmitt L; Montastruc JL; Rascol A
    Rev Neurol (Paris); 1987; 143(8-9):608-11. PubMed ID: 3671965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When a Parkinson's disease patient starts to hallucinate.
    Poewe W
    Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of levodopa on cognition of idiopathic Parkinson's disease].
    Alonso-Prieto E; Michel-Esteban E; Trujillo-Matienzo C; Palmero-Soler E
    Neurologia; 2004 Dec; 19(10):710-8. PubMed ID: 15568168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.